Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue?
They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...
StockStory.org on MSN
Exact Sciences (EXAS): Buy, sell, or hold post Q3 earnings?
What a time it’s been for Exact Sciences. In the past six months alone, the company’s stock price has increased by a massive 152%, reaching $103.18 per share. This was partly due to its solid ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Achieve Life Sciences is a late-stage pharma company awaiting FDA approval for Cytisinicline, a novel smoking cessation ...
A colorectal cancer blood test candidate from Exact Sciences fell short in its pivotal study, but the company is still in the hunt to provide an alternative to the liquid biopsy that was first to ...
On 20 January 2026, Ropes & Gray’s Global Life Sciences Regulatory & Compliance team hosted the “Life Sciences Regulatory Outlook 2026” webinar.
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Exact Sciences announced on Wednesday that it acquired the rights to a blood-based ...
Oracle announced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to empower pharmaceutical, medical device, research, and life sciences organizations to accelerate ...
Morgridge Hall opened to UW-Madison students this semester. It houses the School of Computer, Data and Information Sciences. The new building is entirely donor-funded, the second such project on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results